Investigation of Effective Factors on Treatment Adherence Dimensions and Glycosylated Hemoglobin in Diabetic Patients in Aran and Bidgol in 2019

Glycosylated hemoglobin is used to achieve glycemic control in diabetes, and adherence to treatment is the amount of behavioral therapy performed by an individual. This study aimed to determine effective factors on treatment adherence dimensions and glycosylated hemoglobin in diabetic patients at Aran and Bidgol in 2019.

This was a descriptive-analytical study on diabetic patients referred to Aran and Bidgol health centers from 2019 to 2020. Data were collected through the Madanlu treatment adherence questionnaire and measuring the latest HbA1c level in the patient’s file during the last three months. Literate patients completed the questionnaire, and the illiterate ones were interviewed. Data were analyzed using multiple regression tests and the Pearson correlation coefficient.

The mean age of participants was 60.04±10.75 and the duration of treatment was 9.46±6.81 years. The number (%) was 258(67%) for women, 302(78.4%) for married, 234(60.8%) for employed, 381(99%) for type 2 diabetes. According to the multiple regression test, the amount of glycosylated hemoglobin decreases for each unit of increasing participation in treatment by 0.088, combination by 0.038 and adherence to treatment by 0.156. Also, the value of glycosylated hemoglobin is increases 0.056 for each unit of increasing in commitment to treatment and 0.089 for each unit of tact in execution. R2 was 0.683 and P <0.001.

Glycosylated hemoglobin level has a negative and significant correlation with treatment adherence rate. Due to the improvement of glycosylated hemoglobin levels as a result of better adherence to treatment, promotional interventions are recommended to increase adherence to treatment.